Geographic variation exists in stimulant drug use in U.S.

08/11/2013 |

U.S. researchers looked at 24.1 million stimulant prescriptions for insured and uninsured attention-deficit/hyperactivity disorder patients, and found that about 2.5% of youths aged 17 and younger and 6% of those aged 18 and older received stimulant drugs in March 2008. Wide variation in treatment prevalence among states and counties indicate disparities between clinical practice guidelines and actual practice, according to the study authors. The findings appear in the journal Psychiatric Services.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ